Treatment of Ventricular Tachycardia

Initial Assessment and Treatment

• The American College of Cardiology recommends immediate synchronized DC cardioversion for hemodynamically unstable VT, starting at 100J, escalating to 200J then 360J if needed 1, 2, 3
• Unstable VT is defined by hypotension (systolic BP ≤90 mmHg) 4, chest pain or acute heart failure 5, 2, and heart rate ≥150 beats/min 4, 2
• For pulseless VT, follow the VF protocol with immediate unsynchronized defibrillation 4, 2

Treatment Algorithm for Hemodynamically Unstable VT

• Start with 100J synchronized shock, escalate to 200J, then 360J if unsuccessful 4, 2
• Sedate the conscious but unstable patient immediately before cardioversion 1, 2
• If VT recurs after cardioversion, administer antiarrhythmic drugs to prevent reinitiation 3

Treatment Algorithm for Hemodynamically Stable Monomorphic VT

• Procainamide is the preferred first-line agent for stable monomorphic VT, demonstrating the greatest efficacy among antiarrhythmics 1, 2
• Dosing: 10 mg/kg IV at 50-100 mg/min over 10-20 minutes (maximum dose 10-20 mg/kg) 1, 2
• Monitor continuously for hypotension and QRS widening during administration 2
• Avoid procainamide in patients with severe heart failure or acute myocardial infarction—use amiodarone instead 1

Alternative Agents When Procainamide is Contraindicated

• Amiodarone is preferred in patients with heart failure or suspected ischemia, with dosing: 150 mg (5 mg/kg) IV over 10 minutes, then 1 mg/min infusion for 6 hours, then 0.5 mg/min 1
• Amiodarone reduces life-threatening arrhythmias, required shocks, and symptomatic VT episodes 1
• Sotalol may be considered for stable monomorphic VT, but exercise caution due to significant beta-sympatholytic properties 1

Special Considerations for Polymorphic VT

• For polymorphic VT with normal QT interval (likely ischemia-related), consider IV beta-blockers and treat underlying ischemia aggressively 2
• For polymorphic VT with prolonged QT (Torsades de Pointes), administer IV magnesium sulfate: 8 mmol bolus followed by 2.5 mmol/h infusion 4, 2
• Correct electrolyte abnormalities (potassium, magnesium) 1

Critical Pitfalls to Avoid

• Never assume wide-complex tachycardia is supraventricular—when in doubt, treat as VT 3
• Avoid calcium channel blockers (verapamil, diltiazem) in VT with structural heart disease, as they may precipitate hemodynamic collapse and worsen outcomes 6, 3

Long-Term Management Considerations

• After acute stabilization, beta-blockers are the cornerstone for catecholaminergic polymorphic VT 1, 2
• Consider ICD implantation for secondary prevention in structural heart disease 2
• Urgent catheter ablation is recommended for incessant VT or electrical storm in scar-related heart disease 1, 3

Monitoring Requirements

• Continuous ECG monitoring is mandatory for all VT treatment 1
• Measure and normalize serum potassium and magnesium before initiating antiarrhythmics 1
• Monitor QTc interval—discontinue drug if QTc prolongs to ≥500 ms 1
• Facility must have cardiac resuscitation capabilities immediately available 5, 1